-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The recommendations of the European Union Against Rheumatism (EULAR) provide valuable guidance for the management of rheumatoid arthritis (RA) .
However, although the proposed treatment changes reflect the complex interactions between the disease and a wider range of patients and clinical factors, leading to more and more people realizing the term "hard-to-treat RA", there are still some patients There are symptoms .
A recent international survey of rheumatologists highlighted the management issues and characteristics perceived in this patient category; the results confirmed that the needs of this subgroup of RA patients are not being met
.
The survey shows that in addition to new drugs, new management methods are needed to optimize the treatment of these patients
A recent international survey of rheumatologists highlighted the management issues and characteristics perceived in this patient category; the results confirmed that the needs of this subgroup of RA patients are not being met
The task force responsible for "Developing EULAR recommendations for the integrated management of difficult-to-treat rheumatoid arthritis" aims to make recommendations for this underserved group of patients
Method: The steering committee drafted a definition based on an international survey by rheumatologists, which included suggested terms
.
The working group (including rheumatologists, nurses, health professionals, and patients) discussed and revised this in face-to-face meetings until sufficient agreement was reached (evaluated by voting)
Methods: Results: (1) (2) Quality of life (3)
In summary, the main goal of RA management is to achieve sustained remission or at least reduce disease activity in accordance with the current EULAR recommended steps
.
For D2T RA patients who have not reached the treatment goal, a new management method is needed
The main goal of RA management is to achieve sustained remission or at least reduce disease activity in accordance with the current EULAR recommended steps
Original: Nagy G, Roodenrijs NMT, Welsing PM, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Blaas E, Senolt L, Szekanecz Z, Choy E, Dougados M, Jacobs JW, Geenen R, Bijlsma HW, Zink A, Aletaha D, Schoneveld L, van Riel P, Gutermann L, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM.
EULAR definition of difficult-to-treat rheumatoid arthritis.
Leave a message here
